| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/11/2007 | US20070010581 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
| 01/11/2007 | US20070010554 Aryl substituted pyridines and the use thereof |
| 01/11/2007 | US20070010535 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological atates |
| 01/11/2007 | US20070010534 Novel compounds |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |
| 01/11/2007 | US20070010528 excellent efficacy, oral absorbability, sustained effect, fewer side effects; for thrombosis; anticoagulants; N-(4-((4-( 3-((6-chloro-2-naphthyl)sulfonyl)propanoyl)-1-piperazinyl)methyl)-3-methyl-1,3-thiazol-2(3H)-ylidene)-N-methylamine |
| 01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010490 T-type calcium channel blockers |
| 01/11/2007 | US20070010483 Glucocerebroside treatment of liver disorders |
| 01/11/2007 | US20070010479 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010463 Remedies for diseases caused by strengthened vascular smooth muscle using 14-membered ring macrolid compounds |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010456 Therapeutic agents for low HDL-cholesterolemia |
| 01/11/2007 | US20070010442 Inhibitor of vascular endothelial cell growth factor |
| 01/11/2007 | US20070010436 Remedy for cardiomyopathy |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070010010 Method for efficient transfer of human blastocyst-derived stem cell (hbs cells) from a feeder-supported to a feeder-free culture system |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009554 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009528 Antibodies to masp-2 |
| 01/11/2007 | US20070009519 Immunoregulatory Antibodies and Uses Thereof |
| 01/11/2007 | US20070009513 Novel method of screening |
| 01/11/2007 | US20070009481 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 01/11/2007 | US20070009444 Method for preparing powder exhibiting low susceptibility to electrification |
| 01/11/2007 | DE102005031577A1 Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and / or nisoldipine and an angiotensin II antagonist |
| 01/11/2007 | DE102005028862A1 Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Substituted heterocycles, their use as a medicament as well as pharmaceutical compositions containing them |
| 01/11/2007 | CA2650656A1 Cytokine receptor modulators and uses thereof |
| 01/11/2007 | CA2614315A1 Activator of peroxisome proliferator activated receptor d |
| 01/11/2007 | CA2614193A1 Zofenopril calcium in polymorph form c |
| 01/11/2007 | CA2614110A1 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 01/11/2007 | CA2614102A1 Core 2 glcnac-t inhibitors |
| 01/11/2007 | CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/11/2007 | CA2613828A1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance. |
| 01/11/2007 | CA2613585A1 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 01/11/2007 | CA2613343A1 Compositions comprising arachidonic acid and docosapentaenoic acid for ameliorating reduced higher brain functions resyktubg from organic brain lesions |
| 01/11/2007 | CA2613059A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 01/10/2007 | EP1742052A1 Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 01/10/2007 | EP1741780A2 High affinity oligonucleotide ligands to growth factors |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741712A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of Nebivolol |
| 01/10/2007 | EP1741709A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 01/10/2007 | EP1741708A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1741697A1 Crystal comprising (2r)-2-propyloctoic acid and amine |
| 01/10/2007 | EP1741440A1 Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders |
| 01/10/2007 | EP1741439A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 01/10/2007 | EP1741434A1 The use of timosaponin bii in preparing the drug or produce of preventing and treating stroke |
| 01/10/2007 | EP1741429A2 Processes for preparing torsemide |
| 01/10/2007 | EP1740699A1 Connexin 40 tissue specific gene mutations |
| 01/10/2007 | EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors |
| 01/10/2007 | EP1740552A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 01/10/2007 | EP1740540A1 Phenyl acetamides |
| 01/10/2007 | EP1740271A1 A method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern |
| 01/10/2007 | EP1521583B1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 01/10/2007 | EP1418915B1 Neuroprotective drug |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1416885B1 Devices for delivery of therapeutic agents with variable release profile |
| 01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/10/2007 | EP1355632B1 Amlodipine free base |
| 01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 01/10/2007 | EP1301534B1 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/10/2007 | EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 01/10/2007 | EP1109803B1 Substituted imidazoles having cytokine inhibitory activity |
| 01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | CN1894344A Compounds for dual photodiagnosis and therapy |
| 01/10/2007 | CN1894280A Glycosylation-deficient hepatocyte growth factor |
| 01/10/2007 | CN1894273A Peptide inhibiting angiotensin converting enzyme |
| 01/10/2007 | CN1894256A Method for preparing spironolactone compounds |
| 01/10/2007 | CN1894245A Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE2 inhibitors |
| 01/10/2007 | CN1894238A Diamine derivatives |
| 01/10/2007 | CN1894233A Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| 01/10/2007 | CN1894210A Prolinylarylacetamides |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893979A Remedy for angitis |
| 01/10/2007 | CN1893965A Synergistic composition for treating hyperlipemia |
| 01/10/2007 | CN1893963A Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 01/10/2007 | CN1893957A Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 01/10/2007 | CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 01/10/2007 | CN1893932A Microemulsion preconcentrate comprising a renin inhibitor |
| 01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891693A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891687A Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 01/10/2007 | CN1891297A Medicinal composition containing angiotensin II receptor agonist and fibric acid compound |
| 01/10/2007 | CN1891296A Medicinal composition containing calcium agonist and phenoxy acid compound |
| 01/10/2007 | CN1891287A Nano compound musk injection preparion, and its preparing method |
| 01/10/2007 | CN1891280A Nano Mailuoning injection preparation and its preparing method |
| 01/10/2007 | CN1891279A Capsule for treating cardio-cerebrovasular disease |
| 01/10/2007 | CN1891278A Chinese medicine for treating hypotension |
| 01/10/2007 | CN1891277A Medicinal composition for treating coronary disease, and its preparing method and use |
| 01/10/2007 | CN1891269A Chinese medicine preparation for treating cardio-cerebrovascular disease, and its preparing method |